Joe Lachance is an Assistant Professor in the School of Biological Sciences at Georgia Institute of Technology and a member of the Cell and Molecular Biology Research Program at Winship Cancer Institute.

Lachance received his Ph.D. in Genetics from Stony Brook University in Stony Brook, New York. He conducted his postdoctoral studies as a NIH Kirschstein postdoctoral fellow at the University of Pennsylvania.

Lachance's research is in the areas of human evolutionary genomics, population genetics, and health disparities. His lab integrates large genome-scale datasets with evolutionary theory and computer simulations. They have found evidence of ancient introgression in Africa, inferred that the leading edge of the out-of-Africa migration involved an excess of males, discovered that genetic risks of cancer have decreased over evolutionary time, and identified novel targets of positive selection.

Pinar Keskinocak is the H. Milton and Carolyn J. Stewart School Chair and Professor in the H. Milton Stewart School of Industrial and Systems Engineering at Georgia Tech. She is also co-founder and director of the Center for Health and Humanitarian Systems. Previously, she served as the College of Engineering ADVANCE Professor and as interim associate dean for faculty development and scholarship. Prior to joining Georgia Tech, she worked at IBM T.J. Watson Research Center. She received her Ph.D. in Operations Research from Carnegie Mellon University, and her M.S. and B.S. in Industrial Engineering from Bilkent University.

Keskinocak's research focuses on the applications of operations research and management science with societal impact, particularly health and humanitarian applications, supply chain management, and logistics/transportation. Her recent work has addressed infectious disease modeling (including Covid-19, malaria, Guinea worm, pandemic flu), evaluating intervention strategies, and resource allocation; catch-up scheduling for vaccinations; hospital operations management; disaster preparedness and response (e.g., prepositioning inventory); debris management; centralized and decentralized price and lead time decisions. She has worked on projects with companies, governmental and non-governmental organizations, and healthcare providers, including American Red Cross, CARE, Carter Center, CDC, Children’s Healthcare of Atlanta, Emory University, and Intel Corporation.

She is an INFORMS Fellow and currently serves as the president of INFORMS. Previously she served as the Secretary of INFORMS, a department editor for Operations Research (Policy Modeling and Public Sector area), associate editor for Manufacturing & Service Operations Management, and INFORMS Vice President of Membership and Professional Recognition. She is the co-founder and past-president of INFORMS Section on Public Programs, Service, and Needs, and the president of the INFORMS Health Applications Society.

Greeshma Agasthya (she/her/hers) is an Assistant Professor in the Nuclear & Radiological Engineering and Medical Physics Program at the George W. Woodruff School of Mechanical Engineering at Georgia Institute of Technology. She leads the Computational Medical Physics Laboratory, and her research interests are: (1) developing multiscale digital twins for personalized radiation dosimetry for imaging, therapy, and theranostics, (2) modeling and simulations to assess novel radiation protocols from cancer diagnosis to cancer treatment, and (3) developing AI frameworks to model patient trajectories for early intervention and treatment in oncology.

Previously, she was a research scientist at Oak Ridge National Laboratory in the Advanced Computing for Health Sciences section. Agasthya received her doctorate in Biomedical Engineering from Duke University and completed her postdoctoral training at Emory University's Winship Cancer Institute. She has experience in medical imaging research, modeling and simulation for radiation dosimetry, and AI and Machine learning for healthcare. Agasthya has developed and used multi-scale modeling and simulations of the human body for virtual clinical trials, radiation dosimetry, and optimization of medical imaging systems for cancer applications. She has worked on artificial intelligence (AI) for cancer surveillance, predicting disease outcomes, and clinical decision support. She has collaborated with experts in medical physics, radiology, cardiology, computer engineering, and statistics to tackle interdisciplinary challenges in medical physics and biomedical engineering. She has worked on imaging modalities including neutron imaging, x-ray radiography, computed tomography (CT), and tomosynthesis systems for cancer applications.

Alexander Vlahos is an Assistant Professor in the Wallace H. Coulter Department of Biomedical Engineering at Georgia Tech and Emory University. Alexander received his B.S. in Biochemistry from McMaster University and his Ph.D. from the University of Toronto under the supervision of Professor Michael Sefton. His Ph.D. work focused on developing an injectable bioartificial pancreas that could be delivered underneath the skin. He then transitioned to mammalian synthetic biology, where he conducted his postdoctoral work as an HFSP long-term fellow at Stanford University with Professor Xiaojing Gao.

His research integrates principles from synthetic biology, protein engineering, and tissue engineering to develop synthetic protein circuits for mammalian cellular engineering. The Vlahos lab synergizes synthetic biology and tissue engineering to create programmable gene and cell therapies for biomedical applications in regenerative medicine, cancer, and autoimmune disease. His lab has three main research themes, including 1) generating protein sensors to sense changes in internal cell states or the external microenvironment, 2) programming engineered cells to model cell-to-cell communication and elucidate the dynamics and expression of key signals that govern fibrosis and immune rejection, and 3) applying synthetic protein circuits to modulate the immune system and improve cell transplantation.

Justin Kim is an Associate Professor in the School of Chemistry and Biochemistry. He received his A.B. in Chemistry and Physics and an A.M. in Chemistry from Harvard College in 2003 then received his Ph.D. in Organic Chemistry from the Massachusetts Institute of Technology in 2013. After a postdoctoral fellowship as a Miller Institute Fellow at UC Berkeley and at Stanford University, he joined the faculty of the Department of Cancer Biology at Dana-Farber Cancer Institute and the Department of Biological Chemistry and Molecular Pharmacology at Harvard Medical School in 2016 as an Assistant Professor. He later joined the faculty at Georgia Tech in 2024. He is the recipient of the NIH Director’s New Innovator Award (2018), Thieme Chemistry Journal Award (2021), and the NSF CAREER Award (2023). Professor Kim’s research program is defined by the development of biologically relevant reactions for use in chemistry, biology, and materials science. His primary research interests are in expanding the functional repertoire of bioorthogonal chemistry, specifically exploring new bond-forming and breaking methods that enable platforms for discovering and targeting small molecule-protein and protein-protein interactions as well as for creating functionally dynamic biomaterials.

Julie Champion is the William R. McLain Endowed Term Professor in the School of Chemical and Biomolecular Engineering at Georgia Institute of Technology. She earned her B.S.E. in chemical engineering from the University of Michigan and Ph.D. in chemical engineering at the University of California Santa Barbara. She was an NIH postdoctoral fellow at the California Institute of Technology. Champion is a fellow of the American Institute for Medical and Biological Engineering and has received awards including American Chemical Society Women Chemists Committee Rising Star, NSF BRIGE Award, Georgia Tech Women in Engineering Faculty Award for Excellence in Teaching, Georgia Tech BioEngineering Program Outstanding Advisor Award. Professor Champion’s current research focuses on design and self-assembly of functional nanomaterials made from engineered proteins for applications in immunology, cancer, and biocatalysis.

Dr. Borodovsky and his group develop machine learning algorithms for computational analysis of biological sequences: DNA, RNA and proteins. Our primary focus is on prediction of protein-coding genes and regulatory sites in genomic DNA. Probabilistic models play an important role in the algorithm framework, given the probabilistic nature of biological sequence evolution.

Jaydev P. Desai, Ph.D, is currently a Professor and BME Distinguished Faculty Fellow in the Wallace H. Coulter Department of Biomedical Engineering at Georgia Tech. Prior to joining Georgia Tech in August 2016, he was a Professor in the Department of Mechanical Engineering at the University of Maryland, College Park (UMCP). He completed his undergraduate studies from the Indian Institute of Technology, Bombay, India, in 1993. He received his M.A. in Mathematics in 1997, M.S. and Ph.D. in Mechanical Engineering and Applied Mechanics in 1995 and 1998 respectively, all from the University of Pennsylvania. He was also a Post-Doctoral Fellow in the Division of Engineering and Applied Sciences at Harvard University. He is a recipient of several NIH R01 grants, NSF CAREER award, and was also the lead inventor on the "Outstanding Invention of 2007 in Physical Science Category" at the University of Maryland, College Park. He is also the recipient of the Ralph R. Teetor Educational Award. In 2011, he was an invited speaker at the National Academy of Sciences "Distinctive Voices" seminar series on the topic of "Robot-Assisted Neurosurgery" at the Beckman Center. He was also invited to attend the National Academy of Engineering's 2011 U.S. Frontiers of Engineering Symposium. He has over 150 publications, is the founding Editor-in-Chief of the Journal of Medical Robotics Research, and Editor-in-Chief of the Encyclopedia of Medical Robotics (currently in preparation). His research interests are primarily in the area of image-guided surgical robotics, rehabilitation robotics, cancer diagnosis at the micro-scale, and rehabilitation robotics. He is a Fellow of the ASME and AIMBE.